GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a truly shift in how we handle type 2 diabetes . These new medications work by mimicking the body’s inherent GLP-1 hormone , which supports https://bookmarkingfeed.com/story21591302/glp-1-a-major-approach-in-diabetes-care